Les effets secondaires du vaccin antioreillons (antiourlien)

Transcription

Extrait du Info-vaccination.be
http://info-vaccination.be/?Les-effets-secondaires-du-vaccin,15
Les effets secondaires du
vaccin antioreillons
(antiourlien)
- Documentation - Les différents effets secondaires des vaccins - Le vaccin antioreillons (anti-ourlien) -
Date de mise en ligne : jeudi 3 juin 2010
Description :
Quels sont les effets secondaires de la vaccination antioreillon ?
Info-vaccination.be
Copyright © Info-vaccination.be
Page 1/5
complications neurologiques
•
méningites aseptiques (CIZMAN M. et al. 1989) [1], (TESOVIC G. et al. 1993) [2], (SUGIURA A et al. 1991) [3
], (COLVILLE A. et al. 1992) [4], (PELTOLA H. 1993) [5], (DOURADO I. et al. 2000.) [6] : cette méningite
aseptique peut être observée avec le vaccin antiourlien seul ou avec le vaccin rougeole et rubéole (RRO) : à
première vue la souche virale Urabe entraîne plus fréquemment des méningites aseptiques.
purpura thrombopénique (NIEMINEM et al. 1993) [7]
[1]
Cizman, M., Mozetic, M., Radescek-Rakar, R., Pleterski-Rigler, D., & Susec-Michieli, M. (1989). Aseptic meningitis after vaccination against measles and mumps. Pediatr
[details][url]
Infect Dis J, 8(5), 302-308.
[toggle visibility]
Abstract: This retrospective study (1979 to 1986) investigated the possible etiologic relationship between vaccination and aseptic meningitis in 115 hospitalized children
who became ill within 30 days of vaccination with the Leningrad 3 strain of mumps virus and the Edmonston-Zagreb strain of measles virus. The etiologic viral diagnosis was
based on serologic tests and the isolation of virus from cell cultures which distinguished between attenuated and “virulent” mumps virus. The incidence of
mumps vaccine-associated meningitis was 1/1000 vaccine recipients. In 92% of children the incubation period was 11 to 25 days and 28% had associated swelling of the
salivary glands. Sixteen cases (13.9%) had a positive cerebrospinal fluid culture (attenuated mumps virus, 6 cases; “virulent” mumps virus, 7 cases;
echoviruses, 3 cases). Clustering of cases, seasonal occurrence and age of the patients suggested causal relationship with the vaccination in the majority of children. In 4
patients with attenuated virus isolation from cerebrospinal fluid the incubation period ranged from 17 to 20 days. Clinical findings did not differ from natural mumps
meningitis. The course was uncomplicated and at discharge the patients had no sequelae. Measles virus was never found as a cause of the meningitis. The mumps vaccine
virus should be recognized as one of the causative agents of aseptic meningitis in countries where less attenuated mumps vaccine is used.
Keywords: Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Measles Vaccine/*adverse effects; Measles virus/isolation & purification/pathogenicity;
Meningitis/*epidemiology; Meningitis, Aseptic/*epidemiology/etiology; Mumps Vaccine/*adverse effects; Mumps virus/isolation & purification/pathogenicity; Retrospective
Studies; Vaccines, Attenuated/adverse effects; Yugoslavia
Permanent link
| Save citation: RTF PDF LaTeX
| Export record: BibTeX Endnote ISI RIS Atom XML MODS XML ODF XML Word XML
[2]
Page 2/5
Tesovic, G., Begovac, J., & Bace, A. (1993). Aseptic meningitis after measles, mumps, and rubella vaccine. Lancet, 341(8859), 1541.
[toggle visibility]
[details][url]
Keywords: Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Male; Measles Vaccine/*adverse effects; Measles-Mumps-Rubella Vaccine; Meningitis,
Aseptic/*etiology; Mumps Vaccine/*adverse effects; Rubella Vaccine/*adverse effects; Vaccination/*adverse effects
Permanent link
[3]
Sugiura, A., & Yamada, A. (1991). Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J, 10(3), 209-213.
[toggle visibility]
[details][url]
Abstract: In 1989 a nationwide surveillance of neurologic complications after the administration of mumps vaccine was conducted in Japan, based on the notification of
cases and the testing of mumps viruses isolated from cerebrospinal fluid for their relatedness to the vaccine by nucleotide sequence analysis. Among 630,157 recipients of
measles-mumps-rubella trivalent (MMR) vaccine containing the Urabe Am9 mumps vaccine, there were at least 311 meningitis cases suspected to be vaccine-related. In 96
of these 311 cases, mumps virus related to the vaccine was isolated from cerebrospinal fluid. The unusually high incidence may have been partly a result of the adverse
media publicity of the problem at the time of surveillance. We analyzed clinical features of 165 and 27 laboratory-confirmed mumps vaccine-related meningitis cases that
occurred among the recipients of MMR and monovalent mumps vaccines, respectively, during a 1-year period after the introduction of MMR vaccine. The incidence of
vaccine-related meningitis was similar among the recipients of MMR and monovalent Urabe Am9 mumps vaccines. Meningitis was generally mild and there were no
sequelae from the illness. The complication was more frequent among male than among female children.
Keywords: Child; Child, Preschool; Drug Combinations; Female; Humans; Incidence; Infant; Japan/epidemiology; Male; Measles Vaccine/*adverse effects;
Measles-Mumps-Rubella Vaccine; Meningitis, Aseptic/diagnosis/epidemiology/*etiology; Mumps Vaccine/*adverse effects; Mumps virus/genetics/isolation & purification;
Nucleotide Mapping; Retrospective Studies; Rubella Vaccine/*adverse effects
Permanent link
[4]
Colville, A., & Pugh, S. (1992). Mumps meningitis and measles, mumps, and rubella vaccine. Lancet, 340(8822), 786.
[toggle visibility]
[details][url]
Keywords: Drug Combinations; Great Britain/epidemiology; Humans; Incidence; Infant; Measles Vaccine/*adverse effects; Measles-Mumps-Rubella Vaccine; Meningitis,
Viral/epidemiology/*etiology; Mumps/epidemiology/*etiology; Mumps Vaccine/*adverse effects; Rubella Vaccine/*adverse effects
Permanent link
[5]
Page 3/5
Peltola, H. (1993). Mumps vaccination and meningitis. Lancet, 341(8851), 994-995.
[toggle visibility]
[details][url]
Keywords: Drug Combinations; Humans; Measles Vaccine/*adverse effects; Measles-Mumps-Rubella Vaccine; Meningitis, Aseptic/*etiology; Mumps Vaccine/*adverse
effects; Rubella Vaccine/*adverse effects; Vaccination/*adverse effects
Permanent link
[6]
Dourado, I., Cunha, S., Teixeira, M. G., Farrington, C. P., Melo, A., Lucena, R., et al. (2000). Outbreak of aseptic meningitis associated with mass vaccination with a
[details][url]
urabe-containing measles-mumps-rubella vaccine: implications for immunization programs. Am J Epidemiol, 151(5), 524-530.
[toggle visibility]
Abstract: A mass immunization campaign with a Urabe-containing measles-mumps-rubella vaccine was carried out in 1997 in the city of Salvador, northeastern Brazil, with
a target population of children aged 1-11 years. There was an outbreak of aseptic meningitis following the mass campaign. Cases of aseptic meningitis were ascertained
through data collected from the records of children admitted to the local referral hospital for infectious diseases between March and October of 1997, using previously
defined eligibility criteria. Vaccination histories were obtained through home visits or telephone calls. Eighty-seven cases fulfilled the study criteria. Of those, 58 cases were
diagnosed after the vaccination campaign. An elevated risk of aseptic meningitis was observed 3 weeks after Brazil's national vaccination day compared with the risk in the
prevaccination period (relative risk = 14.3; 95% confidence interval: 7.9, 25.7). This result was confirmed by a case series analysis (relative risk = 30.4; 95% confidence
interval: 11.5, 80.8). The estimated risk of aseptic meningitis was 1 in 14,000 doses. This study confirms a link between measles-mumps-rubella vaccination and aseptic
meningitis. The authors discuss the implications of this for the organization and planning of mass immunization campaigns.
Keywords: Brazil/epidemiology; Child; Child, Preschool; *Disease Outbreaks; Humans; Incidence; Infant; Measles Vaccine/*adverse effects; Measles-Mumps-Rubella
Vaccine; Meningitis, Aseptic/*epidemiology/etiology/virology; Mumps Vaccine/*adverse effects; *Mumps virus/pathogenicity; Product Surveillance, Postmarketing;
Retrospective Studies; Risk Factors; Rubella Vaccine/*adverse effects; Urban Population; Vaccination/*adverse effects; Vaccines, Combined/adverse effects
Permanent link
[7]
Page 4/5
Nieminen, U., Peltola, H., Syrjala, M. T., Makipernaa, A., & Kekomaki, R. (1993). Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A
[details][url]
report on 23 patients. Acta Paediatr, 82(3), 267-270.
[toggle visibility]
Abstract: An acute thrombocytopenic purpura developed shortly after measles-mumps-rubella vaccination in 23 of approximately 700,000 children immunized over a period
of seven years. The mean interval from inoculation to the onset of purpura was 19 days. Bone marrow aspirates obtained from 13 patients showed increased or normal
amounts of megakaryocytes. Platelet survival time was markedly shortened in the two patients studied. Fifteen patients recovered (the platelet count exceeded 100 x 10(9)/l)
in one month, five in two months and two in six months. Increase in platelet-associated immunoglobulin was detected in 10 of 15 patients. Circulating antiplatelet
autoantibodies (AAb) against glycoprotein IIb/IIIa were detected in 5 of 15 patients. The findings are compatible with an autoimmune mechanism triggered by immune
response to measles-mumps-rubella vaccination. As evaluated by the clinical course and the presence of AAb, post-vaccination thrombocytopenic purpura appears to be
indistinguishable from childhood acute idiopathic thrombocytopenic purpura.
Keywords: Acute Disease; Antigen-Antibody Complex/blood; Blood Platelets/immunology; Child; Child, Preschool; Drug Combinations; Female; Follow-Up Studies;
Humans; Immunoglobulin A/blood; Infant; Male; Measles Vaccine/*adverse effects; Measles-Mumps-Rubella Vaccine; Mumps Vaccine/*adverse effects; Purpura,
Thrombocytopenic/blood/epidemiology/*etiology; Rubella Vaccine/*adverse effects; Time Factors
Permanent link
Page 5/5

Les effets secondaires du vaccin antioreillons (antiourlien)

Transcription

Documents pareils

Les effets secondaires du vaccin antirougeole (antimorbilleux)

Unjustified scare or reasonable scepticism? Vaccine Safety

Vaccine Developing the next generation of vaccinologists

Which Pharmacovigilance for Vaccines?

Priorix - Article 30 referral - European Medicines Agency

Priorix Art. 30

Screening Checklist for Contraindications to Vaccines for Adults

Summary of the WHO Position Paper on Vaccines against Hepatitis

Hepatitis B vaccine and the risk of CNS inflammatory demyelination

World Health Organization Vaccine Recommendations: Scientific

Calais FR-GB 2016-v1

Rapid communications

No epidemiological evidence for infant vaccinations

Gastronomy and local products - Office de tourisme de Gisors

Multifrontal QR Factorization for Multicore Architectures over

Vaccination against measles: a neverending story

Global Immunization News (GIN)

Pre-existing immunity against vaccine vectors – friend or foe?

Human papillomavirus (HPV) vaccine policy and evidence

Durable Antibody Responses Following One Dose of the Bivalent

RENDEZ-VOUS IN LENS

Introduction to Vaccines